Skip to main content
. 2024 Apr 2;221(6):e20232387. doi: 10.1084/jem.20232387

Table 1.

Syndromic features of JAK1-mediated disease in six affected probandsa

Proband P3 P7 P9 P11 P13 P16
Age in years (at time of study) 14 4 21 7 39 7
Race/ethnicity (self-reported) European/French African American Ashkenazi Jewish Ashkenazi Jewish Mestizo S. American Ashkenazi Jewish
JAK1 variant c.415C>T; p.E139K c.1516C>T; p.R506C c.1516C>T; p.R506C c.1516C>T; p.R506C c.2099G>A; p.S700N c.2953G>A; p.V985I
Neonatal/developmental
Recurrent infections
Growth deceleration
Adverse reactions to vaccines
Autoimmunity
Myasthenia gravis
Autoimmune hepatitis
Autoimmune thrombocytopenia
Other autoimmune
Atopy (excluding dermatitis)
Food allergy
Asthma
Allergic rhinitis
Colitis (GI inflammation)
IBD
Diarrhea/constipation (non-IBD)
Eosinophilic esophagitis
Dermatitis
Atopic dermatitis
Hematologic
Peripheral leukocyte anomaly
Peripheral eosinophilia
Ig abnormalities
Family history (of any category)
Neonatal/developmental sum 2 1 0 3 2 1
Autoimmunity sum 1 0 1 0 3 0
Atopy sum 2 1 0 2 2 1
Colitis sum 1 1 1 1 1 2
Dermatitis sum 1 1 0 1 0 1
Hematologic sum 2 2 0 2 2 2
Family history 1 0 1 1 0 0
Grand total 10 6 3 10 10 7
a

Check marks (✓) indicate pertinent positives in medical history. Dashes (−) indicate pertinent negatives in medical history. Results reported in binary terms (yes/no) (i.e., whether or not a sign/symptom was present, not how many times a given sign/symptom was present).